“…For phosphoglucose isomerase [Walsh et al, 1989], aldolase [Walsh et al, 1989;Volker et al, 1995], triosephosphate isomerase (TPI) [Orosz et al, 2000], glyceraldehyde-3-phosphate dehydrogenase (GAPDH) [Walsh et al, 1989;Somers et al, 1990;Volker et al, 1995;Andrade et al, 2004;Chuong et al, 2004], phosphoglycerate kinase (PGK) [Walsh et al, 1989], and pyruvate kinase (PK) [Walsh et al, 1989;Volker et al, 1995;Kovacs et al, 2003], binding has been demonstrated by copelleting with MTs. In the case of TPI, binding of the native protein is relatively weak, but a mutant form found in a human disease shows much greater to binding to MTs [Orosz et al, 1999]. Others, including hexokinase (HK), phosphofructokinase (PFK), GAPDH, enolase, and PK, have been shown to colocalize with MTs in brain extracts (HK, Wagner et al [2001]; PK, Kovacs et al [2003]), myoblasts/muscle (enolase [Keller et al, 2007]), BHK cells (GAPDH [Andrade et al, 2004]) or melanoma cells (PFK [Glass-Marmor and Beitner, 1999]).…”